Premium Reports
Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

 End chart zoom
Medication Administration Barcoding at the Point Of Contact (BPOC) 2008 Medication Administration Barcoding at the Point Of Contact (BPOC) 2008
* A page refresh may be necessary to see the updated image

Medication Administration Barcoding at the Point Of Contact (BPOC) 2008

 
January 4, 2008

Since 2003, KLAS has been monitoring the Medication Administration Barcoding at the point of contact (BPOC) market. In this report, KLAS set out to discover what changes were occurring in marketplace as well as the successes and struggles healthcare providers were encountering. The investigation includes vendor performance ratings from their healthcare providers, bar-code technology implementation time, management reports and interfaces. This 318 page report also features provider feedback relating to labeling unit dose medications and scanning compliance.

Main body and preliminary data vendor products included in the Medication Administration BPOC Report are:

  • Cerner Bridge Medpoint
  • Cerner CareMobile/CareAdmin
  • Epic EpicCare Inpatient MAR
  • GE Centricity Enterprise Medication Charting
  • McKesson Horizon Admin-Rx
  • Meditech BMV
  • Siemens Med Administration Check

This report also contains addendum data for CareFusion Bar Code Medication Administration, Eclipsys Sunrise KBMA, IntelliDOT and Mediware MediMAR.

author - Robert Ellis
Project Manager
Robert Ellis
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

​